Catalent Inc CTLT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 01/31/23 EST
53.55quote price arrow up+0.97 (+1.84%)
Volume
1,378,331
52 week range
40.69 - 115.33
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close53.55
  • 52 Week High115.33
  • 52 Week High Date07/29/22
  • 52 Week Low40.69
  • 52 Week Low Date11/22/22

Key Stats

  • Market Cap9.637B
  • Shares Out179.96M
  • 10 Day Average Volume2.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change18.97

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close53.55
  • 52 Week High115.33
  • 52 Week High Date07/29/22
  • 52 Week Low40.69
  • 52 Week Low Date11/22/22
  • Market Cap9.637B
  • Shares Out179.96M
  • 10 Day Average Volume2.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change18.97

RATIOS/PROFITABILITY

  • EPS (TTM)2.34
  • P/E (TTM)22.91
  • Fwd P/E (NTM)15.80
  • EBITDA (TTM)1.113B
  • ROE (TTM)9.65%
  • Revenue (TTM)4.825B
  • Gross Margin (TTM)32.62%
  • Net Margin (TTM)8.83%
  • Debt To Equity (MRQ)89.45%

EVENTS

  • Earnings Date02/07/2023
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalent Inc

 

Profile

MORE
Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies...
J. Martin Carroll
Chairman of the Board
John Chiminski
Executive Chairman of the Board
Alessandro Maselli
President, Chief Executive Officer, Director
Thomas Castellano
Chief Financial Officer, Senior Vice President
Address
14 Schoolhouse Rd
Somerset, NJ
08873-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
ELAN
Elanco Animal Health Inc
13.73+0.18+1.33%
PRGO
Perrigo Company PLC
37.42+0.04+0.11%
OGN
Organon & Co
30.13+0.56+1.89%
RDY
Dr Reddy's Laboratories Ltd
53.80+0.28+0.52%
UTHR
United Therapeutics Corp
263.17+4.46+1.72%